Welcome: Login | Register

Latest Feature

Podcast: Allergan CEO David Pyott at the MassDevice Big 100 West
Podcast: Allergan CEO David Pyott at the MassDevice Big 100 West

Allergan CEO David Pyott talks Botox, medical devices and the aesthetics industry in this podcast, recorded at the MassDevice Big 100 West.
MassDevice Big 100 with Michael Mahoney and Brian Johnson
Podcast: Boston Scientific CEO Michael Mahoney at the MassDevice Big 100 East

Three months before he took the reins at Boston Scientific, Mike Mahoney told MassDevice his thoughts on how he looked to turnaround the medical device giant in this podcast from the MassDevice Big 100 East
Sanovas CEO Larry Gerrans and the MicroCam technology
Sanovas CEO Gerrans goes linear with new MicroCam

Sanovas' new MicroCam plug-and-play endoscopic imaging system paves the way for a paradigm shift toward linear medical devices for natural orifice surgery, CEO Larry Gerrans tells MassDevice.com.

Data and Healthcare
Podcast: Healthcare giants unite to turn Big Data into medtech savings

A quartet of healthcare giants including UnitedHealth, the largest single health insurer in the U.S., joins forces for the SharedClarity project, aiming to leverage their combined Big Data to get the best devices for the best prices.
The E-bay of medical devices: A conversation with Aptitude's Troy Kirchenbauer
Building the E-bay of medical devices: A conversation with Aptitude's Troy Kirchenbauer

MassDevice talks disruptive business models in the medical device and hospital world with Novation executive and aptitude vice president Troy Kirchenbauer

Most Popular

FDA releases full Edwards Lifesciences warning letter
J&J struggles to bring Synthes into the fold | MassDevice.com On Call
Yale study of Medtronic's Infuse shows it's equivalent to bone graft, but studies were biased
Can C.R. Bard use a windfall to reignite growth?
CareFusion may be weighing 2 very different deals

Latest Jobs

View all jobs

Knowledge Library

FDA Review Patterns of De Novo Submissions
The objective of this analysis was to assess whether timelines associated with the De Novo Process are in line with FDA’s stated goals.    

Latest Video

D+Vice Talk - June 7, 2013 with guest speaker Stephen Simpson, medtech analyst
See video
see more videos >>

Subscribe to the MassDevice Weekly Roundup

Email:

Partnerships pursue artificial pancreas technology

June 19, 2013 by Sony Salzman

Two separate partnerships race to develop an artificial pancreas, the holy grail for treating Type I diabetes.

Partnerships pursue artificial pancreas technology

Two medical technology partnerships are racing to develop artificial pancreas technology that might represent a new chapter in Type I diabetes management.

An artificial pancreas would automate communication between portable, personal glucose monitors and insulin pumps to help manage diabetes without medical supervision.

News Well, Diabetes, Insulin Management

New head for the American Medical Assn. | Personnel Moves

June 19, 2013 by Sony Salzman

The American Medical Assn. names retired U.S. navy captain and ob-gyn Dr. Robert Wah president-elect.

New head for the American Medical Assn. | Personnel Moves

Dr. Robert Wah was named president-elect of the American Medical Assn., the nation's largest network of physicians. Wah, who served on the AMA board from 2011 to 2012, will be officially sworn in as president after a year as president-elect.

News Well, Personnel, Personnel Moves

Vertos Medical drums up $23M

June 19, 2013 by Sony Salzman

Vertos Medical completes a $23 million financing round for its mild outpatient procedure, led by new investor Pitango Venture Capital.

Vertos Medical drums up $23M

Vertos Medical announced a $23 million funding round for its outpatient treatment for lumbar spinal stenosis.

The round, led by new investor Pitango Venture Capital, will be used to commercialize Vertos Medical's mild procedure, according to a press release.

News Well, Funding Roundup, Spinal

Abyrx gets an FDA green light for its absorbable bone putty

June 19, 2013 by Sony Salzman

Abyrx wins an FDA nod for its absorbable hemostatic bone putty used to stop hemorrhaging.

Abyrx gets FDA green light for bone putty

Newly formed medical device company Abyrx added a 3rd putty product to its list of FDA 510(k) clearances. Its Absorbable Hemostatic Bone Putty (AHBP) is a mechanical tamponade (bleeding control) material.

Founded in April, Abyrx was formed from the acquisition of assets from Orthocon and DRG. The Irvington, N.Y.-based company plans to expand its line of hemostasis products, according to a press release.

News Well, 510(k), Regulatory/Complaince, Surgical

Covidien's Mallinckrodt pharma spinout slated to close this month | Wall Street Beat

June 19, 2013 by Brad Perriello

Covidien's spinout of its Mallinckrodt pharmaceuticals business is slated to close later this month.

MassDevice.com Wall Street Beat

Covidien (NYSE:COV) said it expects to close its spinout of the Mallinckrodt pharmaceuticals business by the end of this month, with a distribution of shares in the new company.

Mansfield, Mass.-based Covidien said it will issue 1 single share of Mallinckrodt stock for 8 shares of COV stock to interested investors, will all distributions scheduled for completion by June 28.

News Well, Wall Street Beat

Medical device tax: Consultant calls offshoring concerns 'horse hockey'

June 19, 2013 by Sony Salzman

Concerns that the medical device tax will push companies to lay off workers and move operations overseas are 'horse hockey,' according to consultant Mark Bonifacio.

Medical device tax: Offshoring concerns are 'horse hockey'

Mark Bonifacio, founder of the medical device contract manufacturer APEC and an industry consultant, said medtech companies shouldn't be concerned about the medical device tax that's part of the Affordable Care Act.

News Well, Healthcare Reform, Medical Device Tax

FDA clears OrthoSensor's Verasense knee replacement device

June 19, 2013 by Sony Salzman

The FDA clears OrthoSensor's Verasense device, designed to help surgeons fit knee replacement implants.

FDA clears OrthoSensor's Verasense knee replacement device

The FDA handed OrthoSensor a 510(k) clearance for its Verasense knee system, designed to helps surgeons measure the proper placement and motion during total knee replacement procedures.

The Sunrise, Fla.-based device maker is touting the clearance as the 1st for a system that combines limb alignment and soft tissue-balancing features.

News Well, 510(k), Implants, Knees, Regulatory/Compliance

ArtVentive Medical wins CE Mark for peripheral catheter

June 19, 2013 by Sony Salzman

ArtVentive Medical Group wins CE Mark approval in the European Union for its EOS peripheral vascular endoluminal occlusion device, a self-expanding catheter system.

ArtVentive Medical wins CE Mark for peripheral catheter

ArtVentive Medical Group (OTC:AVTD) announced plans to launch its EOS peripheral vascular endoluminal occlusion system in the European Union following CE Mark approval for the self-expanding catheter device.

News Well, Cardiovascular, Catheters, CE Mark, Regulatory/Compliance
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp